Lüleburgaz Production Facility

The Lüleburgaz Production Facility, scheduled to start operations at the end of 2025, will span 162,000 m² of indoor space — making it one of the largest and most advanced pharmaceutical manufacturing hubs not only in Türkiye, but also across the Middle East and Eastern Europe.

Designed as a state-of-the-art facility in full compliance with GMP standards, the site combines an integrated production approach, efficiency-driven architecture, smart automation systems, and sustainable production models — establishing a strong infrastructure to shape the future of pharmaceutical manufacturing.

The facility stands out not only for its production capacity, but also for its R&D infrastructure. The R&D Center, established in Çerkezköy in 2015, was relocated to Lüleburgaz in July 2025. Enhanced with the latest technologies and advanced infrastructure, it now represents one of the most sophisticated research centers in the Turkish pharmaceutical industry. As a driving force, it plays a pivotal role in guiding VEM’s mission to develop innovative treatment solutions.

With the Lüleburgaz facility, we are not only meeting growing production needs, but also delivering flexible solutions to address the industry’s diverse demands — continuing to provide reliable and accessible healthcare solutions from Türkiye to the world.

Key Facts

• • The largest pharmaceutical production facility in Türkiye and its region
• • Indoor area: 162,000 m²
• • Annual capacity: 500 million units
• • Production lines: 50+
• • Employees: 2,500+